3330-5075 Screening compound: 7-[2-hydroxy-3-(propan-2-yloxy)propyl]-8-[(2E)-2-[(2-hydroxyphenyl)methylidene]hydrazin-1-yl]-3-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione

3330-5075 Screening compound: 7-[2-hydroxy-3-(propan-2-yloxy)propyl]-8-[(2E)-2-[(2-hydroxyphenyl)methylidene]hydrazin-1-yl]-3-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione
3330-5075 Screening compound: 7-[2-hydroxy-3-(propan-2-yloxy)propyl]-8-[(2E)-2-[(2-hydroxyphenyl)methylidene]hydrazin-1-yl]-3-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound 3330-5075
7-[2-hydroxy-3-(propan-2-yloxy)propyl]-8-[(2E)-2-[(2-hydroxyphenyl)methylidene]hydrazin-1-yl]-3-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3330-5075

Molecular Formula

C19H24N6O5 (C19 H24 N6 O5)

Compound Name

7-[2-hydroxy-3-(propan-2-yloxy)propyl]-8-[(2E)-2-[(2-hydroxyphenyl)methylidene]hydrazin-1-yl]-3-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione

IUPAC name

7-[2-hydroxy-3-(propan-2-yloxy)propyl]-8-[(2E)-2-[(2-hydroxyphenyl)methylidene]hydrazin-1-yl]-3-methyl-2367-tetrahydro-1H-purine-26-dione

SMILES

CC(C)OCC(Cn1c(N/N=C/c(cccc2)c2O)nc(N(C)C(N2)=O)c1C2=O)O

InChI

InChI=1S/C19H24N6O5/c1-11(2)30-10-13(26)9-25-15-16(24(3)19(29)22-17(15)28)21-18(25)23-20-8-12-6-4-5-7-14(12)27/h4-8,11,13,26-27H,9-10H2,1-3H3,(H,21,23)(H,22,28,29)/t13-/m0/s1

InChI Key

WXVSBZKPEWFEPC-ZDUSSCGKSA-N

MDL Number (MFCD)

MFCD01879260

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

416.44

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

4.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

11

Partition Coefficient, logP

2.410

Distribution Coefficient, logD

2.407

Water Solubility, LogSw

-2.91

Polar Surface Area

115.384

Acid Dissociation Constant (pKa)

9.50

Base Dissociation Constant (pKb)

1.24

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

36.80

3330-5075 in Drug Discovery

Included in Screening Libraries

Nucleoside Mimetics Library (2197 compounds)

Purine Based Nucleoside Mimetics Library (1131 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Cancer
  • Immune system
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with 3330-5075 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 3330-5075?
Check Price and Availability of 3330-5075, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 3330-5075 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 3330-5075
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 3330-5075
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 3330-5075 available by request